Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4 by Juan José Urquijo, Moisés Diago, M.D., Jaume Boadas, Ramón Planas, Ricard Solá, Juan Angel del Olmo, Javier Crespo, José Carlos Erdozaín, María Dolores Antón, Carlos Arocena, Dolores Suarez, Josep Giné, Josep M Barrera, Javier Gracia-Samaniego, Ricardo Perez, Blai Dalmau, Miguel Montoro

Subjects: Get full text

Sofosbuvir and daclatasvir combination therapy for current hepatitis C virus genotype 4 achieves SVR: a case report of HCV genotype 4 from the Amazon by Andréa Monteiro Tarragô, Grenda Leite Pereira, Flamir da Silva Victória, Adriana Malheiro Alle Marie, Marilú Barbieri Victória

Subjects: Get full text

HCV GENOTYPES AND ITS ASSOCIATION WITH RESPONSE TO TREATMENT by Dr. Aftab Ahmad Khan, Dr. Naghmi asif

Subjects: Get full text

The Outcomes of Direct-acting Antiviral Treatment in 177 Patients with Hepatitis C Virus: A Single-center Experience by Ayşin KILINÇ TOKER, Ayşe TURUNÇ ÖZDEMİR, Esma Eren ERYILMAZ, Duygu ÇERÇİOĞLU ÖZDEMİR, Deniz KALAMAK GÜZEL, Tuğba TOK, Zehra BEŞTEPE DURSUN, Musa GÖKSU, İlhami ÇELİK

Subjects: Get full text

Genotypes of Hepatitis C Virus and Efficacy of Direct-Acting Antiviral Drugs among Chronic Hepatitis C Patients in a Tertiary Care Hospital by Nahed Mohammed Hawsawi, Tamer Saber, Hussein M. Salama, Walaa S. Fouad, Howaida M. Hagag, Hayaa M. Alhuthali, Emad M. Eed, Taisir Saber, Khadiga A. Ismail, Hesham H. Al Qurashi, Samir Altowairqi, Mohmmad Samaha, Dalia El-Hossary

Subjects: Get full text

Identification of NS5B Resistance-Associated Mutations in Hepatitis C Virus Circulating in Treatment Naïve Vietnamese Patients by Nguyen TK, Van Le D

Subjects: Get full text

PEG-Interferon-α ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study by Javier Milara, Maria Outeda-Macias, Mª Dolores Aumente-rubio, Patricio Más-Serrano, Azucena Aldaz, Mª Victoria Calvo, Mª Sergia García-Simón, Marisa Martin-Barbero, Núria Padullés-Zamora, Juan Antonio Schoenenberger, Marianne Saavedra-Aldrich, Enrique Tévar-Alfonso, Ana Saval, Alfonso Pastor-Clerigues, Marta García, Luis Margusino-Framiñan, Jose Luis Montero-Alvarez, Esperanza Merino, Jose Ignacio Herrero, Mónica Beunza, Pablo Conesa-Zamora, Alvaro Gimenez-Manzorro, Dolors Comas-Sugrañes, Manuel Cano-Marron, Elena Jiménez-Mutiloa, Pilar Díaz-Ruíz, Julio Cortijo

Subjects: Get full text

The Influence of Metabolic Factors in Patients with Chronic Viral Hepatitis C Who Received Oral Antiviral Treatment by Oana Irina Gavril, Radu Sebastian Gavril, Florin Mitu, Otilia Gavrilescu, Iolanda Valentina Popa, Diana Tatarciuc, Andrei Drugescu, Andrei Catalin Oprescu, Andreea Gherasim, Laura Mihalache, Irina Mihaela Esanu

Subjects: Get full text

Efficacy of direct-acting antiviral therapy for hepatitis C viral infection. Real-life experience in Bahrain by Abdulla M, Ali H, Nass H, Khamis J, AlQamish J

Subjects: Get full text

Circulating Exosomal miRNA Profiles Predict the Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with Direct-Acting Antiviral-Induced Sustained Viral Response by Saori Itami-Matsumoto, Michiyo Hayakawa, Sawako Uchida-Kobayashi, Masaru Enomoto, Akihiro Tamori, Kazuyuki Mizuno, Hidenori Toyoda, Takeyuki Tamura, Tatsuya Akutsu, Takahiro Ochiya, Norifumi Kawada, Yoshiki Murakami

Subjects: “…sustained viral response…”
Get full text

Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis C by Jesús Quintero, Javier Juampérez, Ecaterina Julio, Vanessa Cabello, Maria Mercadal-Hally, Pere Soler-Palacín, Óscar Segarra, Carlos Rodrigo

Subjects: Get full text

Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination by Akihiro Tamori, Hoang Hai, Sawako Uchida-Kobayashi, Masaru Enomoto, Ritsuzo Kozuka, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, Yuga Teranishi, Kanako Yoshida, Hiroyasu Morikawa, Yoshiki Murakami, Norifumi Kawada

Subjects: Get full text

Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin by Guillermo Cabrera Álvarez, Diana Gόmez-Galicia, Lourdes Rodríguez-Fragoso, Vicente Madrid Marina, Luis Cañedo Dorantes, Miguel Sánchez-Alemán, Nahum Méndez-Sánchez, Jorge Reyes Esparza

Subjects: Get full text

Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up by Paul J. Clark, Patricia C. Valery, James Ward, Simone I. Strasser, Martin Weltman, Alexander Thompson, Miriam T. Levy, Barbara Leggett, Amany Zekry, Julian Rong, Peter Angus, Jacob George, Steven Bollipo, Bruce McGarity, William Sievert, Gerry Macquillan, Edmund Tse, Amanda Nicoll, Amanda Wade, Geoff Chu, Damian Harding, Wendy Cheng, Geoff Farrell, Stuart K. Roberts

Subjects: “…Sustained viral response…”
Get full text

Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV Infection by Yanqin Du, Tanvi Khera, Zhaoli Liu, Magdalena Tudrujek-Zdunek, Anna Dworzanska, Markus Cornberg, Cheng-Jian Xu, Krzysztof Tomasiewicz, Heiner Wedemeyer

Subjects: Get full text

Evaluation of HCV-related liver fibrosis post-successful DAA therapy by Nermine Ehsan, Dina Sweed, Maha Elsabaawy

Subjects: Get full text

An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease by Fabrizio Fabrizi, Roberta Cerutti, Piergiorgio Messa

Subjects: Get full text

High viral load predicts virologic failure in chronic genotype 2 hepatitis C virus-infected patients receiving glecaprevir/pibrentasvir therapy by Wei-Ming Chen, Kuo-Liang Wei, Shui-Yi Tung, Chien-Heng Shen, Te-Sheng Chang, Chih-Wei Yen, Yung-Yu Hsieh, Wen Nan Chiu, Jin Hung Hu, Sheng-Nan Lu, Chao-Hung Hung

Subjects: Get full text

Recent Information on Pan-Genotypic Direct-Acting Antiviral Agents for HCV in Chronic Kidney Disease by Fabrizio Fabrizi, Federica Tripodi, Roberta Cerutti, Luca Nardelli, Carlo M. Alfieri, Maria F. Donato, Giuseppe Castellano

Subjects: Get full text

Changes of esophageal varices in hepatitis C patients after achievement of a sustained viral response by direct‐acting antivirals by Satoshi Takakusagi, Naoto Saito, Takashi Ueno, Takeshi Hatanaka, Masashi Namikawa, Hiroki Tojima, Daichi Takizawa, Atsushi Naganuma, Takashi Kosone, Hirotaka Arai, Ken Sato, Satoru Kakizaki, Hitoshi Takagi, Toshio Uraoka

Subjects: Get full text